GlassScriptPhysician profile
Russell O Beecher
NPI 1265630941
$4,932.11
in general payments reported to CMS, 2019-2025
23 companies · $820 in 2025
The $820 reported for 2025 was more than what 85% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $507 · 2021: $690 · 2022: $673 · 2023: $597 · 2024: $723 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,112 · Education: $27.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,112.29 |
| Education | $27.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,449.02 | 2019-2024 | Senza |
| Boston Scientific Corporation | $828.56 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Relievant Medsystems, INC. | $608.91 | 2019-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $445.06 | 2020-2025 | Belbuca, Xtampza |
| Abbvie INC. | $323.16 | 2022-2025 | Ubrelvy, Botox, Qulipta |
| Globus Medical, INC. | $298.77 | 2025 | Senza, Vyrsa Fix |
| Allergan, INC. | $210.15 | 2019-2022 | |
| Pfizer INC. | $140.05 | 2020-2025 | |
| Painteq LLC | $112.31 | 2022-2024 | Painteq |
| Medtronic, INC. | $83.89 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Stryker Corporation | $66.75 | 2020-2021 | |
| Biotronik Nro, INC. | $64.27 | 2025 | Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $49.06 | 2022 | |
| Nalu Medical, INC. | $43.89 | 2022-2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $42.23 | 2019-2024 | Mild Device Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $35.37 | 2022-2023 | Proclaim |
| Merck Sharp & Dohme LLC | $30.99 | 2020-2021 | |
| Saluda Medical Americas, INC. | $29.81 | 2024 | Evoke |
| Bioventus LLC | $15.05 | 2020 | |
| Protega Pharmaceutials INC | $14.81 | 2025 | Roxybond |
| Medtronic USA, INC. | $13.89 | 2020 | |
| Biodelivery Sciences International, INC. | $13.77 | 2019 | |
| Amgen INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Beecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.